Insider Trading disclosures for Hologic, Inc.

The latest disclosure was made by Charles J. Dockendorff in Hologic, Inc. where a trade of 5,535 Non-qualified Stock Option (Right to Buy) done was reported to US exchanges on Feb. 26, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Charles J. Dockendorff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	5,535	5,535	-		-	Non-qualified Stock Option (Right to Buy)
Charles J. Dockendorff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	1,864	3,436 (0%)	0%		-	Common Stock
Martin D. Madaus	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	1,864	2,206 (0%)	0%		-	Common Stock
Martin D. Madaus	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	5,535	5,535	-		-	Non-qualified Stock Option (Right to Buy)
Amy A. Wendell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	5,535	5,535	-		-	Non-qualified Stock Option (Right to Buy)
Amy A. Wendell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	1,864	22,594 (0%)	0%		-	Common Stock
Stacey D. Stewart	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	5,535	5,535	-		-	Non-qualified Stock Option (Right to Buy)
Stacey D. Stewart	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	1,864	5,168 (0%)	0%		-	Common Stock
Ludwig N. Hantson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	1,864	12,956 (0%)	0%		-	Common Stock
Ludwig N. Hantson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	5,535	5,535	-		-	Non-qualified Stock Option (Right to Buy)
Christiana Stamoulis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	5,535	5,535	-		-	Non-qualified Stock Option (Right to Buy)
Christiana Stamoulis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	1,864	47,336 (0%)	0%		-	Common Stock
Nanaz Mohtashami	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	5,535	5,535	-		-	Non-qualified Stock Option (Right to Buy)
Nanaz Mohtashami	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	1,864	4,181 (0%)	0%		-	Common Stock
Mark Horvath	Div. Pres., Breast & Skeletal	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Feb 2025	958	7,057 (0%)	0%		-	Common Stock
Mark Horvath	Div. Pres., Breast & Skeletal	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Feb 2025	2,844	2,844	-		-	Non-qualified Stock Option (Right to Buy)
Brandon Schnittker	Div. President, GYN Surgical	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.66 per share.	13 Dec 2024	90	6,163 (0%)	0%	73.7	6,629	Common Stock
Martin D. Madaus	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2024	342	342 (0%)	0%		-	Common Stock
Essex D. Mitchell	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Dec 2024	4,526	0	-		-	Non-qualified Stock Option (Right to Buy)
Essex D. Mitchell	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Dec 2024	1,956	0	-		-	Non-qualified Stock Option (Right to Buy)
Essex D. Mitchell	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 76.34 per share.	04 Dec 2024	24,856	27,957 (0%)	0%	76.3	1,897,482	Common Stock
Essex D. Mitchell	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.13 per share.	04 Dec 2024	8,915	52,813 (0%)	0%	71.1	634,124	Common Stock
Essex D. Mitchell	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.35 per share.	04 Dec 2024	7,505	43,898 (0%)	0%	68.4	512,967	Common Stock
Essex D. Mitchell	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.97 per share.	04 Dec 2024	1,956	31,867 (0%)	0%	41.0	80,137	Common Stock
Essex D. Mitchell	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.61 per share.	04 Dec 2024	4,526	36,393 (0%)	0%	45.6	206,431	Common Stock
Essex D. Mitchell	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Dec 2024	8,915	2,972	-		-	Non-qualified Stock Option (Right to Buy)
Essex D. Mitchell	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Dec 2024	7,505	0	-		-	Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan	Director, Chairman, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.54 per share.	14 Nov 2024	6,860	1,234,278 (0%)	0%	77.5	531,924	Common Stock
Karleen M. Oberton	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.54 per share.	14 Nov 2024	1,332	102,108 (0%)	0%	77.5	103,283	Common Stock
John M. Griffin	General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.54 per share.	14 Nov 2024	1,120	182,514 (0%)	0%	77.5	86,845	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.54 per share.	14 Nov 2024	110	11,250 (0%)	0%	77.5	8,529	Common Stock
Essex D. Mitchell	Chief Operating Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.54 per share.	14 Nov 2024	1,341	29,911 (0%)	0%	77.5	103,981	Common Stock
Erik Anderson	Div. Pres., Breast & Skeletal	Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.54 per share.	14 Nov 2024	390	23,231 (0%)	0%	77.5	30,241	Common Stock
Jan Verstreken	Group President, International	Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.54 per share.	14 Nov 2024	630	103,814 (0%)	0%	77.5	48,850	Common Stock
Jennifer Schneiders	President, Diag. Solutions	Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.54 per share.	14 Nov 2024	507	12,096 (0%)	0%	77.5	39,313	Common Stock
Brandon Schnittker	Div. President, GYN Surgical	Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.54 per share.	14 Nov 2024	178	6,253 (0%)	0%	77.5	13,802	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2024	39,677	1,241,138 (0%)	0%		-	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.29 per share.	07 Nov 2024	6,214	1,269,908 (0%)	0%	79.3	492,708	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.76 per share.	07 Nov 2024	68,447	1,201,461 (0%)	0%	78.8	5,390,886	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2024	117,801	117,801	-		-	Non-qualified Stock Option (Right to Buy)
Karleen M. Oberton	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2024	28,047	28,047	-		-	Non-qualified Stock Option (Right to Buy)
Karleen M. Oberton	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.29 per share.	07 Nov 2024	1,161	106,591 (0%)	0%	79.3	92,056	Common Stock
Karleen M. Oberton	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.76 per share.	07 Nov 2024	12,598	93,993 (0%)	0%	78.8	992,218	Common Stock
Karleen M. Oberton	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2024	9,447	103,440 (0%)	0%		-	Common Stock
John M. Griffin	General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.29 per share.	07 Nov 2024	592	186,635 (0%)	0%	79.3	46,940	Common Stock
John M. Griffin	General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.76 per share.	07 Nov 2024	9,299	177,336 (0%)	0%	78.8	732,389	Common Stock
John M. Griffin	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2024	6,298	183,634 (0%)	0%		-	Common Stock
John M. Griffin	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2024	18,698	18,698	-		-	Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn	Principal Accounting Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.76 per share.	07 Nov 2024	190	10,180 (0%)	0%	78.8	14,964	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2024	3,505	3,505	-		-	Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn	Principal Accounting Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.29 per share.	07 Nov 2024	106	10,370 (0%)	0%	79.3	8,405	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2024	1,180	11,360 (0%)	0%		-	Common Stock
Essex D. Mitchell	Chief Operating Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.29 per share.	07 Nov 2024	422	24,614 (0%)	0%	79.3	33,460	Common Stock
Essex D. Mitchell	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2024	32,722	32,722	-		-	Non-qualified Stock Option (Right to Buy)
Essex D. Mitchell	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2024	11,021	31,252 (0%)	0%		-	Common Stock
Essex D. Mitchell	Chief Operating Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.76 per share.	07 Nov 2024	4,383	20,231 (0%)	0%	78.8	345,205	Common Stock
Erik Anderson	Div. Pres., Breast & Skeletal	Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.29 per share.	07 Nov 2024	344	20,295 (0%)	0%	79.3	27,276	Common Stock
Erik Anderson	Div. Pres., Breast & Skeletal	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2024	14,023	14,023	-		-	Non-qualified Stock Option (Right to Buy)
Erik Anderson	Div. Pres., Breast & Skeletal	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2024	4,723	23,621 (0%)	0%		-	Common Stock
Erik Anderson	Div. Pres., Breast & Skeletal	Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.76 per share.	07 Nov 2024	1,397	18,898 (0%)	0%	78.8	110,028	Common Stock
Jan Verstreken	Group President, International	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2024	18,698	18,698	-		-	Non-qualified Stock Option (Right to Buy)
Jan Verstreken	Group President, International	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2024	6,298	104,444 (0%)	0%		-	Common Stock
Jan Verstreken	Group President, International	Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.76 per share.	07 Nov 2024	4,928	98,146 (0%)	0%	78.8	388,129	Common Stock
Jan Verstreken	Group President, International	Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.29 per share.	07 Nov 2024	601	103,074 (0%)	0%	79.3	47,653	Common Stock
Jennifer Schneiders	President, Diag. Solutions	Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.29 per share.	07 Nov 2024	157	6,430 (0%)	0%	79.3	12,449	Common Stock
Jennifer Schneiders	President, Diag. Solutions	Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.76 per share.	07 Nov 2024	125	6,305 (0%)	0%	78.8	9,845	Common Stock
Jennifer Schneiders	President, Diag. Solutions	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2024	6,298	12,603 (0%)	0%		-	Common Stock
Jennifer Schneiders	President, Diag. Solutions	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2024	18,698	18,698	-		-	Non-qualified Stock Option (Right to Buy)
Brandon Schnittker	Div. President, GYN Surgical	Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.29 per share.	07 Nov 2024	138	3,597 (0%)	0%	79.3	10,942	Common Stock
Brandon Schnittker	Div. President, GYN Surgical	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2024	2,834	6,431 (0%)	0%		-	Common Stock
Brandon Schnittker	Div. President, GYN Surgical	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2024	8,414	8,414	-		-	Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan	Director, Chairman, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Nov 2024	118,560	1,276,122 (0%)	0%		-	Common Stock
Karleen M. Oberton	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Nov 2024	23,710	107,752 (0%)	0%		-	Common Stock
John M. Griffin	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Nov 2024	20,746	187,227 (0%)	0%		-	Common Stock
Essex D. Mitchell	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Nov 2024	11,854	25,036 (0%)	0%		-	Common Stock
Erik Anderson	Div. Pres., Breast & Skeletal	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Nov 2024	4,149	20,639 (0%)	0%		-	Common Stock
Jan Verstreken	Group President, International	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Nov 2024	17,780	103,675 (0%)	0%		-	Common Stock
Karleen M. Oberton	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 80.56 per share.	29 Aug 2024	52,679	84,042 (0%)	0%	80.6	4,243,662	Common Stock
Karleen M. Oberton	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Aug 2024	6,725	0	-		-	Non-qualified Stock Option (Right to Buy)
Karleen M. Oberton	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Aug 2024	26,080	0	-		-	Non-qualified Stock Option (Right to Buy)
Karleen M. Oberton	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.85 per share.	29 Aug 2024	6,725	136,721 (0%)	0%	40.8	274,716	Common Stock
Karleen M. Oberton	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.97 per share.	29 Aug 2024	26,080	129,996 (0%)	0%	41.0	1,068,498	Common Stock
Brandon Schnittker	Div. President, GYN Surgical	Sale of securities on an exchange or to another person at price $ 83.11 per share.	06 Aug 2024	476	3,735 (0%)	0%	83.1	39,559	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Sale of securities on an exchange or to another person at price $ 81.99 per share.	01 Aug 2024	5,093	10,476 (0%)	0%	82.0	417,570	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share.	30 Jul 2024	44,039	1,201,601 (0%)	0%	26.2	1,154,262	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Jul 2024	44,039	0	-		-	Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan	Director, Chairman, President and CEO	Sale of securities on an exchange or to another person at price $ 82.32 per share.	30 Jul 2024	20,228	1,157,562 (0%)	0%	82.3	1,665,169	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Sale of securities on an exchange or to another person at price $ 81.44 per share.	30 Jul 2024	16,177	1,177,790 (0%)	0%	81.4	1,317,455	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Sale of securities on an exchange or to another person at price $ 80.60 per share.	30 Jul 2024	7,634	1,193,967 (0%)	0%	80.6	615,300	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Jul 2024	3,672	44,039	-		-	Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan	Director, Chairman, President and CEO	Sale of securities on an exchange or to another person at price $ 80.13 per share.	17 Jul 2024	3,672	1,157,562 (0%)	0%	80.1	294,223	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share.	17 Jul 2024	3,672	1,161,234 (0%)	0%	26.2	96,243	Common Stock
Christiana Stamoulis	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Jul 2024	9,039	0	-		-	Non-qualified Stock Option (Right to Buy)
Christiana Stamoulis	Director	Sale of securities on an exchange or to another person at price $ 79.50 per share.	17 Jul 2024	9,039	45,472 (0%)	0%	79.5	718,601	Common Stock
Christiana Stamoulis	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.74 per share.	17 Jul 2024	9,039	54,511 (0%)	0%	26.7	241,703	Common Stock
Brandon Schnittker	Div. President, GYN Surgical	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.78 per share.	31 May 2024	67	4,211 (0%)	0%	73.8	4,943	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Gift of securities by or to the insider at price $ 0.00 per share.	23 May 2024	57,875	1,157,213 (0%)	0%		0	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Gift of securities by or to the insider at price $ 0.00 per share.	19 Apr 2024	12,000	1,215,088 (0%)	0%		0	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Gift of securities by or to the insider at price $ 0.00 per share.	19 Apr 2024	12,000	1,227,088 (0%)	0%		0	Common Stock
Scott T. Garrett	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Mar 2024	7,402	0	-		-	Non-qualified Stock Option (Right to Buy)
Scott T. Garrett	Director	Sale of securities on an exchange or to another person at price $ 75.50 per share.	14 Mar 2024	16,441	48,611 (0%)	0%	75.5	1,241,296	Common Stock
Scott T. Garrett	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.04 per share.	14 Mar 2024	7,402	65,052 (0%)	0%	36.0	266,768	Common Stock
Scott T. Garrett	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.74 per share.	14 Mar 2024	9,039	57,650 (0%)	0%	26.7	241,703	Common Stock
Scott T. Garrett	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Mar 2024	9,039	0	-		-	Non-qualified Stock Option (Right to Buy)
Charles J. Dockendorff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Mar 2024	1,572	3,037 (0%)	0%		-	Common Stock
Charles J. Dockendorff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Mar 2024	4,536	4,536	-		-	Non-qualified Stock Option (Right to Buy)
Charles J. Dockendorff	Director	Sale of securities on an exchange or to another person at price $ 76.21 per share.	07 Mar 2024	1,465	1,572 (0%)	0%	76.2	111,648	Common Stock
Scott T. Garrett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Mar 2024	4,536	4,536	-		-	Non-qualified Stock Option (Right to Buy)
Scott T. Garrett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Mar 2024	1,572	48,611 (0%)	0%		-	Common Stock
Sally Wellinghoff Crawford	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Mar 2024	1,572	132,927 (0%)	0%		-	Common Stock
Sally Wellinghoff Crawford	Director	Sale of securities on an exchange or to another person at price $ 76.40 per share.	07 Mar 2024	9,039	132,927 (0%)	0%	76.4	690,607	Common Stock
Sally Wellinghoff Crawford	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.74 per share.	07 Mar 2024	9,039	141,966 (0%)	0%	26.7	241,703	Common Stock
Sally Wellinghoff Crawford	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Mar 2024	4,536	4,536	-		-	Non-qualified Stock Option (Right to Buy)
Sally Wellinghoff Crawford	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Mar 2024	9,039	0	-		-	Non-qualified Stock Option (Right to Buy)
Amy A. Wendell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Mar 2024	1,572	20,730 (0%)	0%		-	Common Stock
Amy A. Wendell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Mar 2024	4,536	4,536	-		-	Non-qualified Stock Option (Right to Buy)
Stacey D. Stewart	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Mar 2024	1,572	3,304 (0%)	0%		-	Common Stock
Stacey D. Stewart	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Mar 2024	4,536	4,536	-		-	Non-qualified Stock Option (Right to Buy)
Ludwig N. Hantson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Mar 2024	1,572	11,092 (0%)	0%		-	Common Stock
Ludwig N. Hantson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Mar 2024	4,536	4,536	-		-	Non-qualified Stock Option (Right to Buy)
Christiana Stamoulis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Mar 2024	1,572	45,472 (0%)	0%		-	Common Stock
Christiana Stamoulis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Mar 2024	4,536	4,536	-		-	Non-qualified Stock Option (Right to Buy)
Nanaz Mohtashami	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Mar 2024	4,536	4,536	-		-	Non-qualified Stock Option (Right to Buy)
Nanaz Mohtashami	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Mar 2024	1,572	2,317 (0%)	0%		-	Common Stock
Oberton Karleen M.	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 75.00 per share.	29 Jan 2024	14,940	103,916 (0%)	0%	75	1,120,500	Common Stock
J. Dockendorff Charles	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2024	7,551	0	-		-	Non-qualified Stock Option (Right to Buy)
J. Dockendorff Charles	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.44 per share.	02 Jan 2024	7,551	17,482 (0%)	0%	38.4	290,260	Common Stock
Charles J. Dockendorff	Director	Sale of securities on an exchange or to another person at price $ 72.00 per share.	02 Jan 2024	16,017	1,465 (0%)	0%	72	1,153,224	Common Stock
Dunne Peter Paul	SVP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Dec 2023	3,554	3,554	-		-	Non-qualified Stock Option (Right to Buy)
Dunne Peter Paul	SVP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Dec 2023	1,231	10,643 (0%)	0%		-	Common Stock
Garrett T. Scott	Director	Sale of securities on an exchange or to another person at price $ 68.71 per share.	11 Dec 2023	10,000	47,039 (0%)	0%	68.7	687,116	Common Stock
Jan Verstreken	Group President, International	Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.97 per share.	30 Jun 2023	322	78,426 (0%)	0%	81.0	26,072	Common Stock
Scott T. Garrett	Director	Sale of securities on an exchange or to another person at price $ 79.72 per share.	15 Jun 2023	10,000	57,039 (0%)	0%	79.7	797,240	Common Stock
Essex D. Mitchell	Div. President, GYN Surgical	Sale of securities on an exchange or to another person at price $ 83.73 per share.	05 May 2023	2,390	7,212 (0%)	0%	83.7	200,115	Common Stock
Charles J. Dockendorff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2023	1,465	6,725 (0%)	0%		-	Common Stock
Charles J. Dockendorff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2023	4,210	4,210	-		-	Non-qualified Stock Option (Right to Buy)
Scott T. Garrett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2023	1,465	67,039 (0%)	0%		-	Common Stock
Scott T. Garrett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2023	4,210	4,210	-		-	Non-qualified Stock Option (Right to Buy)
Sally Wellinghoff Crawford	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2023	1,465	131,355 (0%)	0%		-	Common Stock
Sally Wellinghoff Crawford	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2023	4,210	4,210	-		-	Non-qualified Stock Option (Right to Buy)
Amy A. Wendell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2023	1,465	19,158 (0%)	0%		-	Common Stock
Amy A. Wendell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2023	4,210	4,210	-		-	Non-qualified Stock Option (Right to Buy)
Stacey D. Stewart	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2023	1,465	1,732 (0%)	0%		-	Common Stock
Stacey D. Stewart	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2023	4,210	4,210	-		-	Non-qualified Stock Option (Right to Buy)
Ludwig N. Hantson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2023	4,210	4,210	-		-	Non-qualified Stock Option (Right to Buy)
Ludwig N. Hantson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2023	1,465	9,520 (0%)	0%		-	Common Stock
Christiana Stamoulis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2023	4,210	4,210	-		-	Non-qualified Stock Option (Right to Buy)
Christiana Stamoulis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2023	1,465	43,900 (0%)	0%		-	Common Stock
Namal Nawana	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2023	4,210	4,210	-		-	Non-qualified Stock Option (Right to Buy)
Namal Nawana	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Mar 2023	1,465	18,221 (0%)	0%		-	Common Stock
Erik Anderson	Div. Pres., Breast & Skeletal	Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.06 per share.	01 Mar 2023	381	10,311 (0%)	0%	79.1	30,122	Common Stock
Charles J. Dockendorff	Director	Gift of securities by or to the insider at price $ 0.00 per share.	07 Feb 2023	1,336	0 (0%)	0%		0	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Sale of securities on an exchange or to another person at price $ 85.28 per share.	07 Feb 2023	9,128	14,298 (0%)	0%	85.3	778,445	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Feb 2023	9,128	0	-		-	Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.97 per share.	07 Feb 2023	9,128	23,426 (0%)	0%	41.0	373,974	Common Stock
Stacey D. Stewart	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2023	267	267 (0%)	0%		-	Common Stock
Stacey D. Stewart	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2023	768	768	-		-	Non-qualified Stock Option (Right to Buy)
John M. Griffin	General Counsel	Gift of securities by or to the insider at price $ 0.00 per share.	05 Dec 2022	2,989	165,955 (0%)	0%		0	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Sale of securities on an exchange or to another person at price $ 76.02 per share.	30 Nov 2022	12,501	2,313,970 (0%)	0%	76.0	950,326	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Sale of securities on an exchange or to another person at price $ 75.43 per share.	30 Nov 2022	20,999	2,326,471 (0%)	0%	75.4	1,584,039	Common Stock
Kevin R. Thornal	Group Pres, Global Diagnostics	Sale of securities on an exchange or to another person at price $ 75.37 per share.	15 Nov 2022	6,628	62,368 (0%)	0%	75.4	499,552	Common Stock
Kevin R. Thornal	Group Pres, Global Diagnostics	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Nov 2022	12,490	0	-		-	Non-qualified Stock Option (Right to Buy)
Kevin R. Thornal	Group Pres, Global Diagnostics	Sale of securities on an exchange or to another person at price $ 75.30 per share.	15 Nov 2022	12,490	62,368 (0%)	0%	75.3	940,509	Common Stock
Kevin R. Thornal	Group Pres, Global Diagnostics	Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.85 per share.	15 Nov 2022	12,490	74,858 (0%)	0%	40.9	510,217	Common Stock
John M. Griffin	General Counsel	Sale of securities on an exchange or to another person at price $ 76.07 per share.	14 Nov 2022	23,634	172,212 (0%)	0%	76.1	1,797,909	Common Stock
John M. Griffin	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Nov 2022	26,902	0	-		-	Non-qualified Stock Option (Right to Buy)
John M. Griffin	General Counsel	Sale of securities on an exchange or to another person at price $ 76.49 per share.	14 Nov 2022	3,268	168,944 (0%)	0%	76.5	249,979	Common Stock
John M. Griffin	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.85 per share.	14 Nov 2022	26,902	195,846 (0%)	0%	40.9	1,098,947	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share.	09 Nov 2022	95,422	2,539,247 (0%)	0%	26.2	2,501,011	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share.	09 Nov 2022	5,776	2,486,825 (0%)	0%	72.1	416,507	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Nov 2022	95,422	95,422	-		-	Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan	Director, Chairman, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.93 per share.	09 Nov 2022	96,355	2,347,470 (0%)	0%	75.9	7,316,235	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Sale of securities on an exchange or to another person at price $ 75.94 per share.	09 Nov 2022	42,893	2,443,825 (0%)	0%	75.9	3,257,294	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Sale of securities on an exchange or to another person at price $ 75.57 per share.	09 Nov 2022	52,529	2,486,718 (0%)	0%	75.6	3,969,564	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Sale of securities on an exchange or to another person at price $ 75.64 per share.	09 Nov 2022	43,000	2,443,825 (0%)	0%	75.6	3,252,520	Common Stock
Karleen M. Oberton	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share.	09 Nov 2022	680	133,008 (0%)	0%	72.1	49,035	Common Stock
Karleen M. Oberton	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.93 per share.	09 Nov 2022	15,145	117,863 (0%)	0%	75.9	1,149,960	Common Stock
John M. Griffin	General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.93 per share.	09 Nov 2022	13,141	168,944 (0%)	0%	75.9	997,796	Common Stock
John M. Griffin	General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share.	09 Nov 2022	609	182,085 (0%)	0%	72.1	43,915	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.93 per share.	09 Nov 2022	322	14,207 (0%)	0%	75.9	24,449	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share.	09 Nov 2022	215	14,529 (0%)	0%	72.1	15,504	Common Stock
Kevin R. Thornal	Group Pres, Global Diagnostics	Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.93 per share.	09 Nov 2022	8,780	68,996 (0%)	0%	75.9	666,665	Common Stock
Kevin R. Thornal	Group Pres, Global Diagnostics	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share.	09 Nov 2022	591	77,776 (0%)	0%	72.1	42,617	Common Stock
Essex D. Mitchell	Div. President, GYN Surgical	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share.	09 Nov 2022	201	9,707 (0%)	0%	72.1	14,494	Common Stock
Essex D. Mitchell	Div. President, GYN Surgical	Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.93 per share.	09 Nov 2022	252	9,455 (0%)	0%	75.9	19,134	Common Stock
Erik Anderson	Div. Pres., Breast & Skeletal	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share.	09 Nov 2022	131	10,692 (0%)	0%	72.1	9,446	Common Stock
Jan Verstreken	Group President, International	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share.	09 Nov 2022	135	80,663 (0%)	0%	72.1	9,735	Common Stock
Jan Verstreken	Group President, International	Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.93 per share.	09 Nov 2022	1,915	78,748 (0%)	0%	75.9	145,406	Common Stock
Elisabeth A. Hellmann	SVP, Human Resources	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share.	09 Nov 2022	194	10,479 (0%)	0%	72.1	13,989	Common Stock
Elisabeth A. Hellmann	SVP, Human Resources	Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.93 per share.	09 Nov 2022	285	10,194 (0%)	0%	75.9	21,640	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.71 per share.	07 Nov 2022	4,052	2,492,601 (0%)	0%	73.7	298,673	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2022	106,300	106,300	-		-	Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan	Director, Chairman, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2022	36,987	2,496,653 (0%)	0%		-	Common Stock
Karleen M. Oberton	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2022	7,565	134,376 (0%)	0%		-	Common Stock
Karleen M. Oberton	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2022	21,743	21,743	-		-	Non-qualified Stock Option (Right to Buy)
Karleen M. Oberton	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.71 per share.	07 Nov 2022	688	133,688 (0%)	0%	73.7	50,712	Common Stock
John M. Griffin	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2022	17,394	17,394	-		-	Non-qualified Stock Option (Right to Buy)
John M. Griffin	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2022	6,052	183,296 (0%)	0%		-	Common Stock
John M. Griffin	General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.71 per share.	07 Nov 2022	602	182,694 (0%)	0%	73.7	44,373	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.71 per share.	07 Nov 2022	207	14,744 (0%)	0%	73.7	15,258	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2022	1,176	14,951 (0%)	0%		-	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2022	3,382	3,382	-		-	Non-qualified Stock Option (Right to Buy)
Kevin R. Thornal	Group Pres, Global Diagnostics	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2022	19,327	19,327	-		-	Non-qualified Stock Option (Right to Buy)
Kevin R. Thornal	Group Pres, Global Diagnostics	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.71 per share.	07 Nov 2022	709	78,367 (0%)	0%	73.7	52,260	Common Stock
Kevin R. Thornal	Group Pres, Global Diagnostics	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2022	6,724	79,076 (0%)	0%		-	Common Stock
Essex D. Mitchell	Div. President, GYN Surgical	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.71 per share.	07 Nov 2022	322	9,908 (0%)	0%	73.7	23,735	Common Stock
Essex D. Mitchell	Div. President, GYN Surgical	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2022	4,034	10,230 (0%)	0%		-	Common Stock
Essex D. Mitchell	Div. President, GYN Surgical	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2022	11,596	11,596	-		-	Non-qualified Stock Option (Right to Buy)
Erik Anderson	Div. Pres., Breast & Skeletal	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.71 per share.	07 Nov 2022	126	10,823 (0%)	0%	73.7	9,287	Common Stock
Erik Anderson	Div. Pres., Breast & Skeletal	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2022	9,663	9,663	-		-	Non-qualified Stock Option (Right to Buy)
Erik Anderson	Div. Pres., Breast & Skeletal	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2022	3,362	10,949 (0%)	0%		-	Common Stock
Jan Verstreken	Group President, International	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2022	6,724	80,992 (0%)	0%		-	Common Stock
Jan Verstreken	Group President, International	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2022	19,327	19,327	-		-	Non-qualified Stock Option (Right to Buy)
Jan Verstreken	Group President, International	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.71 per share.	07 Nov 2022	194	80,798 (0%)	0%	73.7	14,300	Common Stock
Elisabeth A. Hellmann	SVP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2022	6,764	6,764	-		-	Non-qualified Stock Option (Right to Buy)
Elisabeth A. Hellmann	SVP, Human Resources	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.71 per share.	07 Nov 2022	243	10,673 (0%)	0%	73.7	17,912	Common Stock
Elisabeth A. Hellmann	SVP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2022	2,353	10,916 (0%)	0%		-	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Nov 2022	103,447	2,459,666 (0%)	0%		-	Common Stock
Karleen M. Oberton	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Nov 2022	7,389	0	-		-	Non-qualified Stock Option (Right to Buy)
Karleen M. Oberton	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Nov 2022	20,872	126,811 (0%)	0%		-	Common Stock
Karleen M. Oberton	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.64 per share.	01 Nov 2022	7,389	141,356 (0%)	0%	37.6	278,122	Common Stock
Karleen M. Oberton	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 72.50 per share.	01 Nov 2022	14,545	126,811 (0%)	0%	72.5	1,054,513	Common Stock
Karleen M. Oberton	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Nov 2022	7,156	0	-		-	Non-qualified Stock Option (Right to Buy)
Karleen M. Oberton	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.96 per share.	01 Nov 2022	7,156	133,967 (0%)	0%	40.0	285,954	Common Stock
John M. Griffin	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Nov 2022	19,642	177,244 (0%)	0%		-	Common Stock
Kevin R. Thornal	Div. President, Diagnostics	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Nov 2022	12,277	72,352 (0%)	0%		-	Common Stock
Jan Verstreken	Group President, International	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Nov 2022	10,436	74,268 (0%)	0%		-	Common Stock
Jan Verstreken	Group President, International	Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.14 per share.	01 Jul 2022	359	63,832 (0%)	0%	70.1	25,180	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2022	3,844	0	-		-	Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn	Principal Accounting Officer	Sale of securities on an exchange or to another person at price $ 78.75 per share.	17 May 2022	3,844	13,532 (0%)	0%	78.8	302,730	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.85 per share.	17 May 2022	3,844	17,376 (0%)	0%	40.8	157,027	Common Stock
Jan Verstreken	Group President, International	Sale of securities on an exchange or to another person at price $ 78.80 per share.	17 May 2022	6,500	64,191 (0%)	0%	78.8	512,168	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Sale of securities on an exchange or to another person at price $ 75.49 per share.	13 May 2022	3,210	13,532 (0%)	0%	75.5	242,333	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.64 per share.	13 May 2022	3,210	16,742 (0%)	0%	37.6	120,824	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 May 2022	3,842	3,844	-		-	Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 May 2022	3,210	0	-		-	Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn	Principal Accounting Officer	Sale of securities on an exchange or to another person at price $ 75.49 per share.	13 May 2022	3,842	13,532 (0%)	0%	75.5	290,033	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.85 per share.	13 May 2022	3,842	17,374 (0%)	0%	40.9	156,946	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Sale of securities on an exchange or to another person at price $ 74.18 per share.	03 May 2022	2,178	13,532 (0%)	0%	74.2	161,564	Common Stock
Charles J. Dockendorff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	1,565	5,260 (0%)	0%		-	Common Stock
Charles J. Dockendorff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	5,293	5,293	-		-	Non-qualified Stock Option (Right to Buy)
Scott T. Garrett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	5,293	5,293	-		-	Non-qualified Stock Option (Right to Buy)
Scott T. Garrett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	1,565	65,574 (0%)	0%		-	Common Stock
Sally Wellinghoff Crawford	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	5,293	5,293	-		-	Non-qualified Stock Option (Right to Buy)
Sally Wellinghoff Crawford	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	1,565	129,890 (0%)	0%		-	Common Stock
Amy A. Wendell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	5,293	5,293	-		-	Non-qualified Stock Option (Right to Buy)
Amy A. Wendell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	1,565	17,693 (0%)	0%		-	Common Stock
Ludwig N. Hantson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	5,293	5,293	-		-	Non-qualified Stock Option (Right to Buy)
Ludwig N. Hantson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	1,565	8,055 (0%)	0%		-	Common Stock
Christiana Stamoulis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	1,565	42,435 (0%)	0%		-	Common Stock
Christiana Stamoulis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	5,293	5,293	-		-	Non-qualified Stock Option (Right to Buy)
Namal Nawana	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	1,565	16,756 (0%)	0%		-	Common Stock
Namal Nawana	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2022	5,293	5,293	-		-	Non-qualified Stock Option (Right to Buy)
Sean S. Daugherty	Group President, BSH & Surg.	Sale of securities on an exchange or to another person at price $ 71.14 per share.	24 Feb 2022	2,179	49,091 (0%)	0%	71.1	155,016	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Sale of securities on an exchange or to another person at price $ 75.79 per share.	19 Nov 2021	2,570	15,604 (0%)	0%	75.8	194,791	Common Stock
Jan Verstreken	Group President, International	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.54 per share.	12 Nov 2021	2,027	70,691 (0%)	0%	73.5	149,066	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.61 per share.	11 Nov 2021	7,345	2,447,670 (0%)	0%	72.6	533,320	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.54 per share.	11 Nov 2021	91,777	2,355,893 (0%)	0%	73.5	6,749,281	Common Stock
Karleen M. Oberton	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.61 per share.	11 Nov 2021	912	105,939 (0%)	0%	72.6	66,220	Common Stock
John M. Griffin	General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.54 per share.	11 Nov 2021	13,184	157,602 (0%)	0%	73.5	969,551	Common Stock
John M. Griffin	General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.61 per share.	11 Nov 2021	1,297	170,786 (0%)	0%	72.6	94,175	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.54 per share.	11 Nov 2021	293	18,174 (0%)	0%	73.5	21,547	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.61 per share.	11 Nov 2021	322	18,467 (0%)	0%	72.6	23,380	Common Stock
Kevin R. Thornal	Div. President, Diagnostics	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.54 per share.	11 Nov 2021	6,833	60,075 (0%)	0%	73.5	502,499	Common Stock
Kevin R. Thornal	Div. President, Diagnostics	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.61 per share.	11 Nov 2021	632	66,908 (0%)	0%	72.6	45,890	Common Stock
Sean S. Daugherty	Group President, BSH & Surg.	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.54 per share.	11 Nov 2021	6,406	51,270 (0%)	0%	73.5	471,097	Common Stock
Sean S. Daugherty	Group President, BSH & Surg.	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.61 per share.	11 Nov 2021	556	57,676 (0%)	0%	72.6	40,371	Common Stock
Elisabeth A. Hellmann	SVP, Human Resources	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.54 per share.	11 Nov 2021	282	8,292 (0%)	0%	73.5	20,738	Common Stock
Elisabeth A. Hellmann	SVP, Human Resources	Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.61 per share.	11 Nov 2021	285	8,574 (0%)	0%	72.6	20,694	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.26 per share.	08 Nov 2021	4,173	2,455,015 (0%)	0%	71.3	297,368	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Nov 2021	118,877	118,877	-		-	Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan	Director, Chairman, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Nov 2021	35,146	2,459,188 (0%)	0%		-	Common Stock
Karleen M. Oberton	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Nov 2021	7,029	107,531 (0%)	0%		-	Common Stock
Karleen M. Oberton	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.26 per share.	08 Nov 2021	680	106,851 (0%)	0%	71.3	48,457	Common Stock
Karleen M. Oberton	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Nov 2021	23,775	23,775	-		-	Non-qualified Stock Option (Right to Buy)
John M. Griffin	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Nov 2021	20,803	20,803	-		-	Non-qualified Stock Option (Right to Buy)
John M. Griffin	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Nov 2021	6,150	173,002 (0%)	0%		-	Common Stock
John M. Griffin	General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.26 per share.	08 Nov 2021	919	172,083 (0%)	0%	71.3	65,488	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Nov 2021	7,132	7,132	-		-	Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn	Principal Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Nov 2021	2,108	19,004 (0%)	0%		-	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.26 per share.	08 Nov 2021	215	18,789 (0%)	0%	71.3	15,321	Common Stock
Kevin R. Thornal	Div. President, Diagnostics	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Nov 2021	20,803	20,803	-		-	Non-qualified Stock Option (Right to Buy)
Kevin R. Thornal	Div. President, Diagnostics	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Nov 2021	6,150	68,130 (0%)	0%		-	Common Stock
Kevin R. Thornal	Div. President, Diagnostics	Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.26 per share.	08 Nov 2021	590	67,540 (0%)	0%	71.3	42,043	Common Stock
Sean S. Daugherty	Group President, BSH & Surg.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Nov 2021	5,272	58,701 (0%)	0%		-	Common Stock
Sean S. Daugherty	Group President, BSH & Surg.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Nov 2021	17,831	17,831	-		-	Non-qualified Stock Option (Right to Buy)
Sean S. Daugherty	Group President, BSH & Surg.	Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.26 per share.	08 Nov 2021	469	58,232 (0%)	0%	71.3	33,421	Common Stock
Jan Verstreken	Group President, International	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Nov 2021	5,272	73,028 (0%)	0%		-	Common Stock
Jan Verstreken	Group President, International	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Nov 2021	17,831	17,831	-		-	Non-qualified Stock Option (Right to Buy)
Jan Verstreken	Group President, International	Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.26 per share.	08 Nov 2021	310	72,718 (0%)	0%	71.3	22,091	Common Stock
Elisabeth A. Hellmann	SVP, Human Resources	Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.26 per share.	08 Nov 2021	194	8,859 (0%)	0%	71.3	13,824	Common Stock
Elisabeth A. Hellmann	SVP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Nov 2021	2,108	9,053 (0%)	0%		-	Common Stock
Elisabeth A. Hellmann	SVP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Nov 2021	7,132	7,132	-		-	Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan	Director, Chairman, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Nov 2021	240,732	2,424,042 (0%)	0%		-	Common Stock
Karleen M. Oberton	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Nov 2021	43,424	100,502 (0%)	0%		-	Common Stock
John M. Griffin	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Nov 2021	43,252	166,852 (0%)	0%		-	Common Stock
Kevin R. Thornal	Div. President, Diagnostics	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Nov 2021	28,764	61,980 (0%)	0%		-	Common Stock
Sean S. Daugherty	Group President, BSH & Surg.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Nov 2021	26,816	53,429 (0%)	0%		-	Common Stock
Jan Verstreken	Group President, International	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Nov 2021	23,087	67,756 (0%)	0%		-	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Gift of securities by or to the insider at price $ 0.00 per share.	25 Sep 2021	5,250	2,182,967 (0%)	0%		0	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Gift of securities by or to the insider at price $ 0.00 per share.	25 Sep 2021	15,000	2,188,217 (0%)	0%		0	Common Stock
Elisabeth A. Hellmann	SVP, Human Resources	Gift of securities by or to the insider at price $ 0.00 per share.	25 Sep 2021	441	6,945 (0%)	0%		0	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.64 per share.	10 Aug 2021	5,000	21,896 (0%)	0%	37.6	188,200	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Aug 2021	5,000	3,210	-		-	Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn	Principal Accounting Officer	Sale of securities on an exchange or to another person at price $ 77.48 per share.	10 Aug 2021	5,000	16,896 (0%)	0%	77.5	387,425	Common Stock
John M. Griffin	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.64 per share.	09 Aug 2021	26,683	150,283 (0%)	0%	37.6	1,004,348	Common Stock
John M. Griffin	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Aug 2021	26,683	0	-		-	Non-qualified Stock Option (Right to Buy)
John M. Griffin	General Counsel	Sale of securities on an exchange or to another person at price $ 75.62 per share.	09 Aug 2021	26,683	123,600 (0%)	0%	75.6	2,017,768	Common Stock
Jan Verstreken	Group President, International	Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.99 per share.	01 Jul 2021	351	44,669 (0%)	0%	68.0	23,864	Common Stock
Sean S. Daugherty	Group President, BSH & Surg.	Sale of securities on an exchange or to another person at price $ 65.02 per share.	10 May 2021	4,001	26,613 (0%)	0%	65.0	260,149	Common Stock
Charles J. Dockendorff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Mar 2021	5,055	5,055	-		-	Non-qualified Stock Option (Right to Buy)
Charles J. Dockendorff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Mar 2021	1,478	3,695 (0%)	0%		-	Common Stock
Scott T. Garrett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Mar 2021	1,478	64,009 (0%)	0%		-	Common Stock
Scott T. Garrett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Mar 2021	5,055	5,055	-		-	Non-qualified Stock Option (Right to Buy)
Sally Wellinghoff Crawford	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Mar 2021	1,478	128,325 (0%)	0%		-	Common Stock
Sally Wellinghoff Crawford	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Mar 2021	5,055	5,055	-		-	Non-qualified Stock Option (Right to Buy)
Amy A. Wendell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Mar 2021	1,478	16,128 (0%)	0%		-	Common Stock
Amy A. Wendell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Mar 2021	5,055	5,055	-		-	Non-qualified Stock Option (Right to Buy)
Ludwig N. Hantson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Mar 2021	1,478	6,490 (0%)	0%		-	Common Stock
Ludwig N. Hantson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Mar 2021	5,055	5,055	-		-	Non-qualified Stock Option (Right to Buy)
Christiana Stamoulis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Mar 2021	1,478	40,870 (0%)	0%		-	Common Stock
Christiana Stamoulis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Mar 2021	5,055	5,055	-		-	Non-qualified Stock Option (Right to Buy)
Namal Nawana	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Mar 2021	5,055	5,055	-		-	Non-qualified Stock Option (Right to Buy)
Namal Nawana	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Mar 2021	1,478	15,191 (0%)	0%		-	Common Stock
Allison P. Bebo	SVP, Human Resources	Sale of securities on an exchange or to another person at price $ 84.06 per share.	05 Feb 2021	6,100	35,680 (0%)	0%	84.1	512,778	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Sale of securities on an exchange or to another person at price $ 84.31 per share.	04 Feb 2021	8,396	16,652 (0%)	0%	84.3	707,867	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Feb 2021	8,396	0	-		-	Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.96 per share.	04 Feb 2021	8,396	25,048 (0%)	0%	40.0	335,504	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Sale of securities on an exchange or to another person at price $ 73.64 per share.	10 Dec 2020	1,477	16,575 (0%)	0%	73.6	108,759	Common Stock
Kevin R. Thornal	Div. President, Diagnostics	Sale of securities on an exchange or to another person at price $ 74.00 per share.	10 Dec 2020	7,633	33,216 (0%)	0%	74.0	564,804	Common Stock
Kevin R. Thornal	Div. President, Diagnostics	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Dec 2020	7,633	0	-		-	Non-qualified Stock Option (Right to Buy)
Kevin R. Thornal	Div. President, Diagnostics	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Dec 2020	9,236	0	-		-	Non-qualified Stock Option (Right to Buy)
Kevin R. Thornal	Div. President, Diagnostics	Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.64 per share.	10 Dec 2020	9,236	42,452 (0%)	0%	37.6	347,643	Common Stock
Kevin R. Thornal	Div. President, Diagnostics	Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.96 per share.	10 Dec 2020	7,633	40,849 (0%)	0%	40.0	305,015	Common Stock
Kevin R. Thornal	Div. President, Diagnostics	Sale of securities on an exchange or to another person at price $ 73.99 per share.	10 Dec 2020	9,236	33,216 (0%)	0%	74.0	683,409	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.63 per share.	01 Dec 2020	439,919	2,203,217 (0%)	0%	69.6	30,631,560	Common Stock
Karleen M. Oberton	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.63 per share.	01 Dec 2020	317	57,078 (0%)	0%	69.6	22,073	Common Stock
John M. Griffin	General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.63 per share.	01 Dec 2020	10,886	123,600 (0%)	0%	69.6	757,992	Common Stock
Allison P. Bebo	SVP, Human Resources	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.63 per share.	01 Dec 2020	5,763	41,780 (0%)	0%	69.6	401,278	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.63 per share.	01 Dec 2020	240	18,052 (0%)	0%	69.6	16,711	Common Stock
Kevin R. Thornal	Div. President, Diagnostics	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.63 per share.	01 Dec 2020	5,450	33,216 (0%)	0%	69.6	379,484	Common Stock
Sean S. Daugherty	Group President, BSH & Surg.	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.63 per share.	01 Dec 2020	4,604	30,614 (0%)	0%	69.6	320,577	Common Stock
Jan Verstreken	Group President, International	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.63 per share.	01 Dec 2020	1,337	45,020 (0%)	0%	69.6	93,095	Common Stock
John M. Griffin	General Counsel	Sale of securities on an exchange or to another person at price $ 70.80 per share.	18 Nov 2020	11,321	146,065 (0%)	0%	70.8	801,482	Common Stock
John M. Griffin	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Nov 2020	22,900	0	-		-	Non-qualified Stock Option (Right to Buy)
John M. Griffin	General Counsel	Sale of securities on an exchange or to another person at price $ 71.35 per share.	18 Nov 2020	11,579	134,486 (0%)	0%	71.4	826,208	Common Stock
John M. Griffin	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.96 per share.	18 Nov 2020	22,900	157,386 (0%)	0%	40.0	915,084	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Sale of securities on an exchange or to another person at price $ 72.58 per share.	17 Nov 2020	5,000	18,292 (0%)	0%	72.6	362,900	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2020	5,000	0	-		-	Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share.	17 Nov 2020	5,000	23,292 (0%)	0%	26.2	131,050	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.20 per share.	12 Nov 2020	8,179	2,643,136 (1%)	0%	70.2	574,166	Common Stock
John M. Griffin	General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.20 per share.	12 Nov 2020	896	134,486 (0%)	0%	70.2	62,899	Common Stock
Allison P. Bebo	SVP, Human Resources	Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.20 per share.	12 Nov 2020	463	47,543 (0%)	0%	70.2	32,503	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Nov 2020	6,542	5,000	-		-	Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn	Principal Accounting Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.20 per share.	12 Nov 2020	293	18,292 (0%)	0%	70.2	20,569	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Sale of securities on an exchange or to another person at price $ 70.60 per share.	12 Nov 2020	6,542	18,585 (0%)	0%	70.6	461,846	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share.	12 Nov 2020	6,542	25,127 (0%)	0%	26.2	171,466	Common Stock
Kevin R. Thornal	Div. President, Diagnostics	Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.20 per share.	12 Nov 2020	598	38,666 (0%)	0%	70.2	41,980	Common Stock
Sean S. Daugherty	Group President, BSH & Surg.	Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.20 per share.	12 Nov 2020	554	35,218 (0%)	0%	70.2	38,891	Common Stock
Jan Verstreken	Group President, International	Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.20 per share.	12 Nov 2020	46	46,357 (0%)	0%	70.2	3,229	Common Stock
Scott T. Garrett	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.35 per share.	09 Nov 2020	11,146	62,531 (0%)	0%	22.3	249,113	Common Stock
Scott T. Garrett	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Nov 2020	11,146	0	-		-	Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan	Director, Chairman, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.84 per share.	09 Nov 2020	7,633	2,651,315 (1%)	0%	69.8	533,089	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Nov 2020	123,801	123,801	-		-	Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan	Director, Chairman, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Nov 2020	36,199	2,658,948 (1%)	0%		-	Common Stock
Karleen M. Oberton	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.84 per share.	09 Nov 2020	912	57,395 (0%)	0%	69.8	63,694	Common Stock
Karleen M. Oberton	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Nov 2020	6,949	58,307 (0%)	0%		-	Common Stock
Karleen M. Oberton	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Nov 2020	23,767	23,767	-		-	Non-qualified Stock Option (Right to Buy)
John M. Griffin	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Nov 2020	21,265	21,265	-		-	Non-qualified Stock Option (Right to Buy)
John M. Griffin	General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.84 per share.	09 Nov 2020	858	135,382 (0%)	0%	69.8	59,923	Common Stock
John M. Griffin	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Nov 2020	6,217	136,240 (0%)	0%		-	Common Stock
Allison P. Bebo	SVP, Human Resources	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.84 per share.	09 Nov 2020	471	48,006 (0%)	0%	69.8	32,895	Common Stock
Allison P. Bebo	SVP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Nov 2020	3,291	48,477 (0%)	0%		-	Common Stock
Allison P. Bebo	SVP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Nov 2020	11,258	11,258	-		-	Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn	Principal Accounting Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.84 per share.	09 Nov 2020	322	18,585 (0%)	0%	69.8	22,488	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Nov 2020	7,505	7,505	-		-	Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn	Principal Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Nov 2020	2,194	18,907 (0%)	0%		-	Common Stock
Kevin R. Thornal	Div. President, Diagnostics	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Nov 2020	5,120	39,896 (0%)	0%		-	Common Stock
Kevin R. Thornal	Div. President, Diagnostics	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Nov 2020	17,512	17,512	-		-	Non-qualified Stock Option (Right to Buy)
Kevin R. Thornal	Div. President, Diagnostics	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.84 per share.	09 Nov 2020	632	39,264 (0%)	0%	69.8	44,139	Common Stock
Sean S. Daugherty	Group President, BSH & Surg.	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.84 per share.	09 Nov 2020	556	35,772 (0%)	0%	69.8	38,831	Common Stock
Sean S. Daugherty	Group President, BSH & Surg.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Nov 2020	4,389	36,328 (0%)	0%		-	Common Stock
Sean S. Daugherty	Group President, BSH & Surg.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Nov 2020	15,010	15,010	-		-	Non-qualified Stock Option (Right to Buy)
Jan Verstreken	Group President, International	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Nov 2020	12,509	12,509	-		-	Non-qualified Stock Option (Right to Buy)
Jan Verstreken	Group President, International	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Nov 2020	3,657	46,435 (0%)	0%		-	Common Stock
Jan Verstreken	Group President, International	Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.84 per share.	09 Nov 2020	32	46,403 (0%)	0%	69.8	2,235	Common Stock
Christiana Stamoulis	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Nov 2020	11,146	0	-		-	Non-qualified Stock Option (Right to Buy)
Christiana Stamoulis	Director	Sale of securities on an exchange or to another person at price $ 74.00 per share.	04 Nov 2020	11,146	39,392 (0%)	0%	74	824,804	Common Stock
Christiana Stamoulis	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.35 per share.	04 Nov 2020	11,146	50,538 (0%)	0%	22.3	249,113	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Nov 2020	900,307	2,622,749 (0%)	0%		-	Common Stock
Karleen M. Oberton	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Nov 2020	16,941	51,358 (0%)	0%		-	Common Stock
John M. Griffin	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Nov 2020	34,716	130,023 (0%)	0%		-	Common Stock
Allison P. Bebo	SVP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Nov 2020	16,797	45,186 (0%)	0%		-	Common Stock
Kevin R. Thornal	Div. President, Diagnostics	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Nov 2020	17,750	34,776 (0%)	0%		-	Common Stock
Sean S. Daugherty	Group President, BSH & Surg.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Nov 2020	17,432	31,939 (0%)	0%		-	Common Stock
Jan Verstreken	Group President, International	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Nov 2020	16,797	42,778 (0%)	0%		-	Common Stock
Karleen M. Oberton	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share.	21 Sep 2020	15,000	43,956 (0%)	0%	26.2	393,150	Common Stock
Karleen M. Oberton	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Sep 2020	5,461	0	-		-	Non-qualified Stock Option (Right to Buy)
Karleen M. Oberton	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Sep 2020	15,000	5,461	-		-	Non-qualified Stock Option (Right to Buy)
Karleen M. Oberton	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share.	21 Sep 2020	5,461	34,417 (0%)	0%	26.2	143,133	Common Stock
Karleen M. Oberton	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 62.50 per share.	21 Sep 2020	15,000	28,956 (0%)	0%	62.5	937,500	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.82 per share.	03 Aug 2020	2,986	19,699 (0%)	0%	23.8	71,127	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Aug 2020	2,986	0	-		-	Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn	Principal Accounting Officer	Sale of securities on an exchange or to another person at price $ 71.23 per share.	03 Aug 2020	2,617	16,713 (0%)	0%	71.2	186,409	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Sale of securities on an exchange or to another person at price $ 71.22 per share.	03 Aug 2020	369	19,330 (0%)	0%	71.2	26,280	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Sale of securities on an exchange or to another person at price $ 71.27 per share.	03 Aug 2020	1,938	16,713 (0%)	0%	71.3	138,121	Common Stock
Peter J. Valenti	Division Pres., Breast Health	Sale of securities on an exchange or to another person at price $ 54.07 per share.	30 Jun 2020	10,493	59,991 (0%)	0%	54.1	567,357	Common Stock
Peter J. Valenti	Division Pres., Breast Health	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	30 Jun 2020	10,493	0	-		-	Non-qualified Stock Option (Right to Buy)
Peter J. Valenti	Division Pres., Breast Health	Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share.	30 Jun 2020	10,493	70,484 (0%)	0%	26.2	275,022	Common Stock
Sally W. Crawford	Director	Sale of securities on an exchange or to another person at price $ 51.99 per share.	22 May 2020	31,950	126,847 (0%)	0%	52.0	1,661,081	Common Stock
Peter J. Valenti	Division Pres., Breast Health	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 May 2020	10,493	10,493	-		-	Non-qualified Stock Option (Right to Buy)
Peter J. Valenti	Division Pres., Breast Health	Sale of securities on an exchange or to another person at price $ 51.82 per share.	22 May 2020	10,493	59,991 (0%)	0%	51.8	543,779	Common Stock
Peter J. Valenti	Division Pres., Breast Health	Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share.	22 May 2020	10,493	70,484 (0%)	0%	26.2	275,022	Common Stock
Kevin R. Thornal	Div. President, Diagnostics	Sale of securities on an exchange or to another person at price $ 51.51 per share.	15 May 2020	13,888	17,026 (0%)	0%	51.5	715,426	Common Stock
Kevin R. Thornal	Div. President, Diagnostics	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 May 2020	13,888	0	-		-	Non-qualified Stock Option (Right to Buy)
Kevin R. Thornal	Div. President, Diagnostics	Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.01 per share.	15 May 2020	13,888	30,914 (0%)	0%	26.0	361,227	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Sale of securities on an exchange or to another person at price $ 50.97 per share.	13 May 2020	190,996	1,722,442 (0%)	0%	51.0	9,735,257	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 May 2020	215,996	0	-		-	Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan	Director, Chairman, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.29 per share.	13 May 2020	215,996	1,913,438 (0%)	0%	22.3	4,814,551	Common Stock
Scott T. Garrett	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 May 2020	24,204	0	-		-	Non-qualified Stock Option (Right to Buy)
Scott T. Garrett	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.34 per share.	01 May 2020	24,204	51,385 (0%)	0%	20.3	492,309	Common Stock
John M. Griffin	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2020	2,773	0	-		-	Non-qualified Stock Option (Right to Buy)
John M. Griffin	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2020	2,133	0	-		-	Non-qualified Stock Option (Right to Buy)
John M. Griffin	General Counsel	Sale of securities on an exchange or to another person at price $ 50.00 per share.	28 Apr 2020	2,133	95,307 (0%)	0%	50	106,650	Common Stock
John M. Griffin	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.38 per share.	28 Apr 2020	2,133	97,440 (0%)	0%	32.4	69,067	Common Stock
John M. Griffin	General Counsel	Sale of securities on an exchange or to another person at price $ 50.00 per share.	28 Apr 2020	2,773	95,307 (0%)	0%	50	138,650	Common Stock
John M. Griffin	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.38 per share.	28 Apr 2020	2,773	98,080 (0%)	0%	32.4	89,790	Common Stock
Sally W. Crawford	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Mar 2020	11,146	0	-		-	Non-qualified Stock Option (Right to Buy)
Sally W. Crawford	Director	Sale of securities on an exchange or to another person at price $ 44.29 per share.	09 Mar 2020	7,846	158,797 (0%)	0%	44.3	347,523	Common Stock
Sally W. Crawford	Director	Sale of securities on an exchange or to another person at price $ 43.57 per share.	09 Mar 2020	3,300	166,643 (0%)	0%	43.6	143,794	Common Stock
Sally W. Crawford	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.35 per share.	09 Mar 2020	11,146	169,943 (0%)	0%	22.3	249,113	Common Stock
Charles J. Dockendorff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2020	7,322	7,322	-		-	Non-qualified Stock Option (Right to Buy)
Charles J. Dockendorff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2020	2,217	22,129 (0%)	0%		-	Common Stock
Scott T. Garrett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2020	2,217	27,181 (0%)	0%		-	Common Stock
Scott T. Garrett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2020	7,322	7,322	-		-	Non-qualified Stock Option (Right to Buy)
Sally W. Crawford	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2020	2,217	158,797 (0%)	0%		-	Common Stock
Sally W. Crawford	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2020	7,322	7,322	-		-	Non-qualified Stock Option (Right to Buy)
Amy A. Wendell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2020	7,322	7,322	-		-	Non-qualified Stock Option (Right to Buy)
Amy A. Wendell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2020	2,217	14,650 (0%)	0%		-	Common Stock
Ludwig N. Hantson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2020	7,322	7,322	-		-	Non-qualified Stock Option (Right to Buy)
Ludwig N. Hantson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2020	2,217	5,012 (0%)	0%		-	Common Stock
Christiana Stamoulis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2020	2,217	39,392 (0%)	0%		-	Common Stock
Christiana Stamoulis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2020	7,322	7,322	-		-	Non-qualified Stock Option (Right to Buy)
Namal Nawana	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2020	7,322	7,322	-		-	Non-qualified Stock Option (Right to Buy)
Namal Nawana	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2020	2,217	13,713 (0%)	0%		-	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Sale of securities on an exchange or to another person at price $ 53.54 per share.	03 Feb 2020	194,396	1,697,442 (0%)	0%	53.5	10,407,184	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Feb 2020	215,996	215,996	-		-	Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan	Director, Chairman, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.29 per share.	03 Feb 2020	215,996	1,891,838 (0%)	0%	22.3	4,814,551	Common Stock
John M. Griffin	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Jan 2020	8,532	2,133	-		-	Non-qualified Stock Option (Right to Buy)
John M. Griffin	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.38 per share.	13 Jan 2020	8,532	103,839 (0%)	0%	32.4	276,266	Common Stock
Karleen M. Oberton	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 51.66 per share.	02 Jan 2020	10,375	34,929 (0%)	0%	51.7	535,993	Common Stock
Karleen M. Oberton	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2020	5,973	0	-		-	Non-qualified Stock Option (Right to Buy)
Karleen M. Oberton	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.45 per share.	02 Jan 2020	10,375	39,331 (0%)	0%	21.5	222,544	Common Stock
Karleen M. Oberton	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2020	10,375	0	-		-	Non-qualified Stock Option (Right to Buy)
Karleen M. Oberton	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 51.85 per share.	02 Jan 2020	5,973	28,956 (0%)	0%	51.8	309,694	Common Stock
Karleen M. Oberton	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.82 per share.	02 Jan 2020	5,973	45,304 (0%)	0%	23.8	142,277	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Dec 2019	4,379	0	-		-	Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn	Principal Accounting Officer	Sale of securities on an exchange or to another person at price $ 52.12 per share.	04 Dec 2019	4,379	18,162 (0%)	0%	52.1	228,225	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.45 per share.	04 Dec 2019	4,379	22,541 (0%)	0%	21.5	93,930	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.32 per share.	01 Dec 2019	4,772	1,697,945 (0%)	0%	51.3	244,899	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Other type of transaction at price $ 51.69 per share.	01 Dec 2019	13,716	1,675,842 (0%)	0%	51.7	708,980	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.32 per share.	01 Dec 2019	8,387	1,689,558 (0%)	0%	51.3	430,421	Common Stock
Karleen M. Oberton	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.32 per share.	01 Dec 2019	235	29,166 (0%)	0%	51.3	12,060	Common Stock
Karleen M. Oberton	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.32 per share.	01 Dec 2019	210	28,956 (0%)	0%	51.3	10,777	Common Stock
Peter J. Valenti	Division Pres., Breast Health	Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.32 per share.	01 Dec 2019	2,119	62,271 (0%)	0%	51.3	108,747	Common Stock
Peter J. Valenti	Division Pres., Breast Health	Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.32 per share.	01 Dec 2019	946	59,991 (0%)	0%	51.3	48,549	Common Stock
Peter J. Valenti	Division Pres., Breast Health	Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.32 per share.	01 Dec 2019	1,334	60,937 (0%)	0%	51.3	68,461	Common Stock
John M. Griffin	General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.32 per share.	01 Dec 2019	1,650	95,307 (0%)	0%	51.3	84,678	Common Stock
Allison P. Bebo	SVP, Human Resources	Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.32 per share.	01 Dec 2019	403	28,389 (0%)	0%	51.3	20,682	Common Stock
Allison P. Bebo	SVP, Human Resources	Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.32 per share.	01 Dec 2019	688	28,792 (0%)	0%	51.3	35,308	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.32 per share.	01 Dec 2019	261	18,402 (0%)	0%	51.3	13,395	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.32 per share.	01 Dec 2019	240	18,162 (0%)	0%	51.3	12,317	Common Stock
Kevin R. Thornal	Div. President, Diagnostics	Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.32 per share.	01 Dec 2019	658	17,026 (0%)	0%	51.3	33,769	Common Stock
Kevin R. Thornal	Div. President, Diagnostics	Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.32 per share.	01 Dec 2019	494	17,684 (0%)	0%	51.3	25,352	Common Stock
Christiana Stamoulis	None	Sale of securities on an exchange or to another person at price $ 49.75 per share.	22 Nov 2019	12,306	37,175 (0%)	0%	49.8	612,224	Common Stock
Christiana Stamoulis	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Nov 2019	12,306	0	-		-	Non-qualified Stock Option (Right to Buy)
Christiana Stamoulis	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.01 per share.	22 Nov 2019	12,306	49,481 (0%)	0%	20.0	246,243	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.45 per share.	22 Nov 2019	4,400	23,063 (0%)	0%	21.5	94,380	Common Stock
Benjamin J. Cohn	Principal Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Nov 2019	4,400	4,379	-		-	Non-qualified Stock Option (Right to Buy)
Benjamin J. Cohn	Principal Accounting Officer	Sale of securities on an exchange or to another person at price $ 50.09 per share.	22 Nov 2019	4,400	18,663 (0%)	0%	50.1	220,400	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.29 per share.	11 Nov 2019	194,396	1,781,811 (0%)	0%	22.3	4,333,087	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Nov 2019	152,529	152,529	-		-	Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan	Director, Chairman, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Nov 2019	21,600	431,992	-		-	Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan	Director, Chairman, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Nov 2019	194,396	453,592	-		-	Non-qualified Stock Option (Right to Buy)
Stephen P. Macmillan	Director, Chairman, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.15 per share.	11 Nov 2019	8,178	1,702,717 (0%)	0%	46.2	377,415	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Nov 2019	21,925	1,710,895 (0%)	0%		-	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Nov 2019	46,183	1,688,970 (0%)	0%		-	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Nov 2019	33,772	1,642,787 (0%)	0%		-	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.29 per share.	11 Nov 2019	21,600	1,609,015 (0%)	0%	22.3	481,464	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Sale of securities on an exchange or to another person at price $ 46.16 per share.	11 Nov 2019	126,956	1,587,415 (0%)	0%	46.2	5,859,908	Common Stock
Stephen P. Macmillan	Director, Chairman, President and CEO	Sale of securities on an exchange or to another person at price $ 45.44 per share.	11 Nov 2019	67,440	1,714,371 (0%)	0%	45.4	3,064,743	Common Stock
Karleen M. Oberton	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Nov 2019	1,554	20,083 (0%)	0%		-	Common Stock
Karleen M. Oberton	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Nov 2019	9,318	29,401 (0%)	0%		-	Common Stock
Karleen M. Oberton	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Nov 2019	30,774	30,774	-		-	Non-qualified Stock Option (Right to Buy)
Peter J. Valenti	Division Pres., Breast Health	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Nov 2019	30,774	30,774	-		-	Non-qualified Stock Option (Right to Buy)
Peter J. Valenti	Division Pres., Breast Health	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Nov 2019	5,612	55,965 (0%)	0%		-	Common Stock
Peter J. Valenti	Division Pres., Breast Health	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Nov 2019	9,318	65,283 (0%)	0%		-	Common Stock
Peter J. Valenti	Division Pres., Breast Health	Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.15 per share.	11 Nov 2019	893	64,390 (0%)	0%	46.2	41,212	Common Stock
John M. Griffin	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Nov 2019	5,612	89,085 (0%)	0%		-	Common Stock
John M. Griffin	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Nov 2019	28,964	28,964	-		-	Non-qualified Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

Near 52W Low of $60.34

High volume today

Insider Trading disclosures for Hologic, Inc.

The latest disclosure was made by Charles J. Dockendorff in Hologic, Inc. where a trade of 5,535 Non-qualified Stock Option (Right to Buy) done was reported to US exchanges on Feb. 26, 2025.

Screeners based on Insider Trading and SAST parameters